Patents by Inventor Dehua Huang

Dehua Huang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11107455
    Abstract: A method for providing a broadband constant beam pattern acoustic array includes providing an array of transducers in a known three dimensional axisymmetric spherical configuration with each transducer element having an associated signal. A user can specify a far field beam pattern for the array. Weightings are calculated for each transducer in the array as being proportional to the voltage that gives the beam pattern power level associated with the bearing for each transducer. Signal power levels for each transducer are modified in accordance with the weightings. The array can be operated for receiving and transmitting signals with a constant beam pattern over a broad range of frequencies.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: August 31, 2021
    Inventor: Dehua Huang
  • Publication number: 20210128565
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: January 12, 2021
    Publication date: May 6, 2021
    Inventors: Matthew Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang, Robert Hubbard, Brandon Jeffy, Jim Leisten, Mehran Moghaddam, Raj K. Raheja, Heather Raymon, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, Tam Minh Tran, Shuichan Xu, JingJing Zhao
  • Patent number: 10940152
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: April 13, 2020
    Date of Patent: March 9, 2021
    Assignee: SIGNAL PHARMACEUTICALS, LLC
    Inventors: Matthew Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang, Robert Hubbard, Brandon Jeffy, Jim Leisten, Mehran Moghaddam, Raj K. Raheja, Heather Raymon, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, Tam Minh Tran, Shuichan Xu, JingJing Zhao
  • Publication number: 20200343497
    Abstract: The disclosure provides a housing of a battery module and a battery module including the housing. The housing includes a first side plate, a second side plate, and a plurality of accommodating cavities for accommodating battery cells being defined separately between the first side plate and the second side plate; the first side plate includes a first outer surface, and a plurality of latching grooves being defined separately at the first outer surface; the second side plate includes a second outer surface, and a plurality of fixing blocks being defined separately at the second outer surface, and one fixing block is engaged with one latching groove. The fixing blocks of the housing can cooperate with the latching grooves of a next housing to achieve the detachable connection of the housings of a battery module. The number of the housing of a battery module can be increased or reduced as needed.
    Type: Application
    Filed: December 20, 2019
    Publication date: October 29, 2020
    Inventors: ZHONGWEI SUN, DEHUA HUANG, CHAO HU, ZHONGLIN WU, WEI BAI
  • Patent number: 10800717
    Abstract: The present invention relates to a palladium-based supported hydrogenation catalyst and a preparation method and application thereof. The catalyst is prepared by the following method: impregnating an Al2O3-containing carrier with an organic solution containing a bipyridine derivative having hydroxy group, optionally drying followed by impregnating with a mixed solution containing the main active component palladium ions and the auxiliary active component Mn+ ions, where M is one selected from Ag, Au, Ni, Pb and Cu; and then optionally drying, and calcining to obtain the catalyst. The preparation method provided by the present invention allows Pd atoms and M atoms to be highly uniformly dispersed on the carrier, which overcomes the adverse impact of the surface tension of the impregnation solution and the solvation effect on the dispersibility of active components.
    Type: Grant
    Filed: June 15, 2018
    Date of Patent: October 13, 2020
    Assignee: PetroChina Company Limited
    Inventors: Chunxia Che, Yulong Liang, Ying Qian, Wei Han, Feng Zhang, Galian Gou, Xilin Jing, Xiaoxin Chang, Qiang Gui, Lifen Gu, Wei Xie, Zhongdong Zhang, Dehua Huang, Duping Tan, Yuan Gao, Lin Cheng
  • Publication number: 20200237768
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: April 13, 2020
    Publication date: July 30, 2020
    Inventors: Matthew Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang, Robert Hubbard, Brandon Jeffy, Jim Leisten, Mehran Moghaddam, Raj K. Raheja, Heather Raymon, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, Tam Minh Tran, Shuichan Xu, JingJing Zhao
  • Patent number: 10646493
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: July 17, 2019
    Date of Patent: May 12, 2020
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Matthew Alexander, Sogole Bahmanyar, John Frederick Boylan, Joshua Hansen, Dehua Huang, Robert Hubbard, Brandon Jeffy, Jim Leisten, Mehran Moghaddam, Raj K. Raheja, Heather Raymon, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, Tam Minh Tran, Shuichan Xu, JingJing Zhao
  • Publication number: 20190336507
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: July 17, 2019
    Publication date: November 7, 2019
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao, Shuichan Xu, Sogole Bahmanyar
  • Publication number: 20190322647
    Abstract: Provided herein are 4-aminoisoindoline-1,3-dione compounds having the following structure: wherein R, Ring A, and n are as defined herein, compositions comprising an effective amount of a 4-aminoisoindoline-1,3-dione compound, and methods for treating or preventing disorders.
    Type: Application
    Filed: April 22, 2019
    Publication date: October 24, 2019
    Inventors: Matthew D. Alexander, Soraya Carrancio, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen, Roy L. Harris, Dehua Huang, Timothy S. Kercher, Antonia Lopez-Girona, Mark A. Nagy, Veronique Plantevin-Krenitsky
  • Patent number: 10398700
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: October 24, 2018
    Date of Patent: September 3, 2019
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Publication number: 20190091230
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: October 24, 2018
    Publication date: March 28, 2019
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Patent number: 10149849
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Grant
    Filed: July 5, 2017
    Date of Patent: December 11, 2018
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Publication number: 20180290949
    Abstract: The present invention relates to a palladium-based supported hydrogenation catalyst and a preparation method and application thereof. The catalyst is prepared by the following method: impregnating an Al2O3-containing carrier with an organic solution containing a bipyridine derivative having hydroxy group, optionally drying followed by impregnating with a mixed solution containing the main active component palladium ions and the auxiliary active component Mn+ ions, where M is one selected from Ag, Au, Ni, Pb and Cu; and then optionally drying, and calcining to obtain the catalyst. The preparation method provided by the present invention allows Pd atoms and M atoms to be highly uniformly dispersed on the carrier, which overcomes the adverse impact of the surface tension of the impregnation solution and the solvation effect on the dispersibility of active components.
    Type: Application
    Filed: June 15, 2018
    Publication date: October 11, 2018
    Inventors: Chunxia Che, Yulong Liang, Ying Qian, Wei Han, Feng Zhang, Galian Gou, Xilin Jing, Xiaoxin Chang, Qiang Gui, Lifen Gu, Wei Xie, Zhongdong Zhang, Dehua Huang, Duping Tan, Yuan Gao, Lin Cheng
  • Patent number: 9882904
    Abstract: Protocol status information is used to perform traffic filtering by dropping messages that are not consistent with the protocol status information. In one embodiment, a method involves comparing message information and protocol status information. The message information is associated with a first message. The protocol status information is obtained in response to one or more second messages, which are conveyed according to a protocol used to assign network addresses to clients. The method also involves determining whether to discard the first message, based on an outcome of the comparison of the message information and the protocol status information. For example, it can be determined that the first message should be discarded, if the message information does not match the protocol status information.
    Type: Grant
    Filed: June 4, 2014
    Date of Patent: January 30, 2018
    Assignee: Cisco Technology, Inc.
    Inventors: Dehua Huang, Adam J. Sweeney, Pradeep S. Sudame, Silviu Dobrota, Premkumar Jonnala
  • Patent number: 9838803
    Abstract: A carbon nanotube thermophone is provided. The thermophone includes high temperature rated shells as protective walls as the top and bottom housing of the thermophone with carbon nanotube sheets affixed between the shells. The shells act as acoustic windows that match the surrounding frequency and acoustic radiation medium. A high temperature rated sealant gasket is used to enclose the shells of the thermophone where gas holes are inserted for interior heavy gas filling. The acoustic resonant frequency is defined by the dimensions of the housing of the thermophone and the sound speed of the filled heavy gas. Each carbon nanotube sheet has an electrode at both ends. Multiple carbon nanotube sheets can electrically tune the impedance to match a driving amplifier impedance load.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: December 5, 2017
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Thomas R Howarth, Dehua Huang
  • Patent number: 9838802
    Abstract: A carbon nanotube thermophone is provided which includes a urethane frame having mounting holes at corners of the frame. Screw holes in the frame are provided for a cable holder. A square shaped carbon nanotube material chip is positioned within the urethane frame. The carbon nanotube material chip can comprise multiple carbon nanotube sheets to electrically tune the impedance to match a driving amplifier impedance load. Wooden spacers assist in positioning the carbon nanotube material chip. A first end of a cable is soldered to the carbon nanotube material chip at electrodes of the material chip. A high temperature rated silicon sealant is used for attachment points on the thermophone.
    Type: Grant
    Filed: September 23, 2016
    Date of Patent: December 5, 2017
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventors: Thomas R Howarth, Dehua Huang
  • Patent number: 9795607
    Abstract: Provided herein are Pyrrolopyrimidine Compounds having the following structure: wherein R1, R2, R3, and L are as defined herein, compositions comprising an effective amount of a Pyrrolopyrimidine Compound, and methods for treating or preventing breast cancer, more particularly triple negative breast cancer, comprising administering an effective amount of such Pyrrolopyrimidine Compounds to a subject in need thereof.
    Type: Grant
    Filed: July 21, 2016
    Date of Patent: October 24, 2017
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang, Jan Elsner, John Boylan, Lida Tehrani, Mark A. Nagy, Raj Kumar Raheja, Paul Erdman, Rama K. Narla, Roy L. Harris, Tam Minh Tran, Jennifer Riggs, Yuhong Ning, Shuichan Xu
  • Publication number: 20170296546
    Abstract: Provided herein are Aminopurine Compounds having the following structures: wherein R1, R2, and R3 are as defined herein, compositions comprising an effective amount of an Aminopurine Compound, and methods for treating or preventing a cancer, for example, melanoma.
    Type: Application
    Filed: July 5, 2017
    Publication date: October 19, 2017
    Inventors: Matthew Alexander, Joshua Hansen, Dehua Huang, Robert Hubbard, Raj K. Raheja, Kimberly Schwarz, Marianne Sloss, Eduardo Torres, JingJing Zhao
  • Patent number: 9783505
    Abstract: Provided herein are diaminopyrimidyl Compounds having the following structures: wherein X, L, R1, and R2 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidyl Compound, and methods for treating or preventing PKC-theta-mediated disorders, or a condition treatable or preventable by inhibition of a kinase, for example, PKC-theta.
    Type: Grant
    Filed: August 19, 2016
    Date of Patent: October 10, 2017
    Assignee: Signal Pharmaceuticals, LLC
    Inventors: Patrick Papa, Brian Edwin Cathers, Andrew Antony Calabrese, Brandon Wade Whitefield, Brydon Bennett, Daniel Cashion, Deborah Mortensen, Dehua Huang, Eduardo Torres, Jason Parnes, John Sapienza, Joshua Hansen, Katerina Leftheris, Matthew Correa, Maria Mercedes Delgado, Raj K. Raheja, Sogole Bahmanyar, Sayee Hegde, Stephen Norris, Veronique Plantevin-Krenitsky
  • Patent number: 9781520
    Abstract: A passive carbon nanotube transducer is provided. The passive carbon nanotube transducer includes shells as protective walls for the top and bottom housing of the transducer with carbon nanotube sheets affixed between the shells. The shells act as acoustic windows that match the surrounding acoustic medium. A gasket encloses the shells and carbon nanotube sheets of the transducer. Each carbon nanotube sheet has an electrode at both ends. Multiple carbon nanotube sheets are capable of sensing sound induced environment temperature deviations and converting electric voltage or current for passive acoustic detection.
    Type: Grant
    Filed: September 20, 2016
    Date of Patent: October 3, 2017
    Assignee: The United States of America as represented by the Secretary of the Navy
    Inventor: Dehua Huang